CN117482167A - 一种治疗艾滋病相关的肺部感染的中药组合物及其中药制剂 - Google Patents
一种治疗艾滋病相关的肺部感染的中药组合物及其中药制剂 Download PDFInfo
- Publication number
- CN117482167A CN117482167A CN202311321048.8A CN202311321048A CN117482167A CN 117482167 A CN117482167 A CN 117482167A CN 202311321048 A CN202311321048 A CN 202311321048A CN 117482167 A CN117482167 A CN 117482167A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- aids
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 76
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 37
- 208000030507 AIDS Diseases 0.000 title claims abstract description 36
- 208000032376 Lung infection Diseases 0.000 title claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 15
- 241001071917 Lithospermum Species 0.000 claims abstract description 15
- 241000405414 Rehmannia Species 0.000 claims abstract description 15
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 15
- 240000000011 Artemisia annua Species 0.000 claims abstract description 14
- 235000001405 Artemisia annua Nutrition 0.000 claims abstract description 14
- 241000218176 Corydalis Species 0.000 claims abstract description 14
- 241000501743 Gentiana macrophylla Species 0.000 claims abstract description 14
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 14
- 239000010440 gypsum Substances 0.000 claims abstract description 14
- 241000612118 Samolus valerandi Species 0.000 claims abstract description 13
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 13
- 235000011477 liquorice Nutrition 0.000 claims abstract description 13
- 239000003937 drug carrier Substances 0.000 claims description 20
- 239000003085 diluting agent Substances 0.000 claims description 19
- 241001598107 Imperata Species 0.000 claims description 14
- 239000000945 filler Substances 0.000 claims description 14
- 208000015181 infectious disease Diseases 0.000 claims description 14
- 239000000853 adhesive Substances 0.000 claims description 12
- 230000001070 adhesive effect Effects 0.000 claims description 12
- 230000002685 pulmonary effect Effects 0.000 claims description 11
- 239000000796 flavoring agent Substances 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 229930006000 Sucrose Natural products 0.000 claims description 8
- 239000005720 sucrose Substances 0.000 claims description 8
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 7
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 7
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 7
- 108010010803 Gelatin Proteins 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 7
- 229930195725 Mannitol Natural products 0.000 claims description 7
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 7
- 229940072056 alginate Drugs 0.000 claims description 7
- 235000010443 alginic acid Nutrition 0.000 claims description 7
- 229920000615 alginic acid Polymers 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 235000010980 cellulose Nutrition 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- 235000013355 food flavoring agent Nutrition 0.000 claims description 7
- 239000008273 gelatin Substances 0.000 claims description 7
- 229920000159 gelatin Polymers 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 235000001727 glucose Nutrition 0.000 claims description 7
- 239000008101 lactose Substances 0.000 claims description 7
- 239000000314 lubricant Substances 0.000 claims description 7
- 239000000594 mannitol Substances 0.000 claims description 7
- 235000010355 mannitol Nutrition 0.000 claims description 7
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 7
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 7
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 7
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- 235000010356 sorbitol Nutrition 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 7
- 239000000811 xylitol Substances 0.000 claims description 7
- 235000010447 xylitol Nutrition 0.000 claims description 7
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 7
- 229960002675 xylitol Drugs 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 241001071795 Gentiana Species 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 239000007884 disintegrant Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 210000002784 stomach Anatomy 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 206010067484 Adverse reaction Diseases 0.000 abstract description 4
- 230000006838 adverse reaction Effects 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 230000007794 irritation Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 240000007171 Imperata cylindrica Species 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 17
- 241000725303 Human immunodeficiency virus Species 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 12
- 206010037660 Pyrexia Diseases 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 230000036436 anti-hiv Effects 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000012059 conventional drug carrier Substances 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 208000000059 Dyspnea Diseases 0.000 description 5
- 206010013975 Dyspnoeas Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 206010008479 Chest Pain Diseases 0.000 description 4
- 210000001744 T-lymphocyte Anatomy 0.000 description 4
- 238000011225 antiretroviral therapy Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 208000032023 Signs and Symptoms Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 3
- 229940124530 sulfonamide Drugs 0.000 description 3
- 238000011269 treatment regimen Methods 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000007521 HIV Seropositivity Diseases 0.000 description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010039424 Salivary hypersecretion Diseases 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 208000026451 salivation Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000015604 Artemisia caruifolia Nutrition 0.000 description 1
- 241000615735 Artemisia carvifolia Species 0.000 description 1
- 241001072256 Boraginaceae Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000501719 Gentiana straminea Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000013537 Helichrysum petiolatum Nutrition 0.000 description 1
- 244000308760 Helichrysum petiolatum Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 208000005384 Pneumocystis Pneumonia Diseases 0.000 description 1
- 206010073755 Pneumocystis jirovecii pneumonia Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000207844 Scrophulariaceae Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960000715 nimodipine Drugs 0.000 description 1
- 201000000317 pneumocystosis Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗艾滋病相关的肺部感染的中药组合物及其中药制剂,具体涉及中药技术领域。所述中药组合物由如下重量份数的原料组成:生石膏15‑45份、生地10‑30份、地骨皮10‑30份、葛根10‑30份、天花粉10‑30份、秦艽5‑20份、青蒿10‑30份、紫草5‑30份、白茅根10‑30份、地丁5‑30份、知母5‑20份、甘草2‑15份。本发明的一种治疗艾滋病相关的肺部感染的中药制剂使用纯中药制剂,避免了对患者胃的刺激和对肝脏产生的毒副作用,经过大量人群实践证实,安全可靠,无明显不良反应,且制备方法简单,对环境无污染,具有极大的推广应用价值。
Description
技术领域
本发明涉及中药技术领域,具体涉及一种治疗艾滋病相关的肺部感染的中药组合物及其中药制剂。
背景技术
艾滋病,即获得性免疫缺陷综合征(acquiredimmunodeficiency syndrome,AIDS),其病原体为人类免疫缺陷病毒(human immunodeficiencyvirus,HIV),亦称艾滋病病毒。联合国艾滋病规划署(UNAIDS)估计,截至2017年底,全球现存活HIV/AIDS患者3690万例,当年新发HIV感染者180万例,有2170万例正在接受高效联合抗反转录病毒治疗(highlyactive antiretroviraltherapy,HAART,俗称“鸡尾酒疗法”,现在又称抗反转录病毒治疗。通过HAART可在较短的时间内控制病毒,使HIV/AIDs患者存活期由原来的几年提高到了数十年,但HAART并不能完全清除病毒。因此,患者需要终生服用抗病毒药物。
HIV/AIDs感染者由于感染后的抵抗力偏低,长期服用药物,也会降低机体的免疫力,患者肺部感染后不易恢复,增加了患者的痛苦程度,因此,发挥中西医结合治疗的优势,从中药中开发出疗效明确治疗艾滋病相关的肺部感染的药物,减轻西药的毒副作用,提高HIV/AIDs患者的生存质量有重要意义。
发明内容
为此,本发明提供一种治疗艾滋病相关的肺部感染的中药组合物及其中药制剂,以解决现有治疗艾滋病相关肺部感染的西药毒副作用强,治疗效果不佳等问题。
为了实现上述目的,本发明提供如下技术方案:
根据本发明一方面提供的一种治疗艾滋病相关的肺部感染的中药组合物,所述中药组合物由如下重量份数的原料组成:生石膏15-45份、生地10-30份、地骨皮10-30份、葛根10-30份、天花粉10-30份、秦艽5-20份、青蒿10-30份、紫草5-30份、白茅根10-30份、地丁5-30份、知母5-20份、甘草2-15份。
进一步的,所述中药组合物由如下重量份数的原料组成:生石膏20-40份、生地15-25份、地骨皮15-25份、葛根15-25份、天花粉15-25份、秦艽6-15份、青蒿15-25份、紫草10-20份、白茅根15-25份、地丁10-20份、知母6-15份、甘草2-10份。
进一步的,所述中药组合物由如下重量份数的原料组成:生石膏30份、生地20份、地骨皮20份、葛根20份、天花粉20份、秦艽10份、青蒿20份、紫草15份、白茅根20份、地丁15份、知母10份、甘草5份。
本发明各原料的作用具体如下:
生石膏:又名"寒水石",主治中风寒热,有解肌发汗,除口干舌焦,头痛牙疼等功能。乃祛瘟解热之良药。
生地:别名生地黄,野地黄、山烟根等,为玄参科植物地黄的块根。甘,寒。归心,肝,肾经。清热凉血、养阴生津。
地骨皮:别名枸杞皮,为茄科、枸杞属植物,是枸杞Lycium chinense Mill.的根皮。性甘,寒。可入药,具有退热除蒸之效,凉血除蒸、清肺降火等功效。
葛根:为豆科植物野葛的干燥根,甘、辛,凉。有解肌退热,透疹,生津止渴,升阳止泻之功效。
天花粉:粉味甘,微苦,性微寒,归肺、胃经。天花粉具有清热泻火、生津止渴、消肿排脓的功效。
秦艽:为龙胆科植物秦艽、麻花秦艽、粗茎秦艽或秦艽的干燥根,具有祛风湿、清湿热、止痹痛的功效,临床用于治疗风湿痹痛、筋脉拘挛、骨节酸痛、日晡潮热、小儿疳积发热等症状。
青蒿:学名:Artemisia carvifolia,苦,辛,寒。归肝、胆经、三焦、肾经。清透虚热,凉血除蒸,解暑,截疟。用于暑邪发热,阴虚发热,夜热早凉,骨蒸劳热,疟疾寒热,湿热黄疸。
紫草:学名:Lithospermum erythrorhizon Sieb.et Zucc.紫草科紫草属多年生草本植物,苦,寒。清热解毒,凉血活血,愈合溃疡的功效。
白茅根:为禾本科植物白茅的根茎。凉血,止血,清热,利尿。治热病烦渴,吐血,衄血,肺热喘急,胃热哕逆,淋病,小便不利,水肿,黄疸。
地丁:地丁草,性寒,味苦,小毒;入心、脾经,清热解毒。治温病高热烦躁,流感,传染性肝炎,肾炎,瘰疬,腮腺炎,疔疮及其它化脓性感染。
知母:性味:苦,寒。入肺、胃、肾经。功能主治:滋阴降火,润燥滑肠。治烦热消渴,骨蒸劳热,肺热咳嗽,大便燥结,小便不利。
甘草:豆科、甘草属多年生草本。甘草的根及根茎性味甘平,归心肺脾胃经。清热解毒、镇咳祛痰、补脾益气。
根据本发明另一方面提供的一种治疗艾滋病相关的肺部感染的中药制剂,所述中药制剂由上述的中药组合物和药学上可接受的载体或稀释剂组成。
进一步的,所述中药制剂为颗粒剂、片剂、胶囊、丸剂、汤剂、糖浆剂。
进一步的,所述药学上可接受的载体或稀释剂是指药学领域常规的药物载体,选自填充剂、粘合剂、崩解剂、润滑剂、表面活性剂或矫味剂中的一种或几种。
进一步的,所述填充剂选自淀粉、蔗糖、乳糖、甘露醇、山梨醇、木糖醇、微晶纤维素或葡萄糖中的一种或几种。
进一步的,所述粘合剂选自纤维素衍生物、藻酸盐、明胶或聚乙烯吡咯烷酮中的一种或几种。
本发明具有如下优点:
本发明一种治疗艾滋病相关肺部感染的中药组合物由生石膏、生地、地骨皮、葛根、天花粉、秦艽、青蒿、紫草、白茅根、地丁、知母、甘草12种中草药混合而成,通过这12中中药材之间的相互协同作用,使得到的中药组合物对于艾滋病相关的肺部感染具有很好的治疗效果,通过大量的临床试验可以看出本发明的中药组合物疗效确切。
本发明的一种治疗艾滋病相关的肺部感染的中药制剂使用纯中药制剂,避免了对患者胃的刺激和对肝脏产生的毒副作用,经过大量人群实践证实,安全可靠,无明显不良反应,且制备方法简单,对环境无污染,具有极大的推广应用价值。
具体实施方式
以下由特定的具体实施例说明本发明的实施方式,熟悉此技术的人士可由本说明书所揭露的内容轻易地了解本发明的其他优点及功效,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
一种治疗艾滋病相关的肺部感染的中药组合物,其特征在于,所述中药组合物由如下重量份数的原料组成:生石膏30份、生地20份、地骨皮20份、葛根20份、天花粉20份、秦艽10份、青蒿20份、紫草15份、白茅根20份、地丁15份、知母10份、甘草5份。
实施例2
一种治疗艾滋病相关的肺部感染的中药组合物,其特征在于,所述中药组合物由如下重量份数的原料组成:生石膏15份、生地10份、地骨皮10份、葛根10份、天花粉10份、秦艽5份、青蒿10份、紫草5份、白茅根10份、地丁5份、知母5份、甘草2份。
实施例3
一种治疗艾滋病相关的肺部感染的中药组合物,其特征在于,所述中药组合物由如下重量份数的原料组成:生石膏45份、生地30份、地骨皮30份、葛根30份、天花粉30份、秦艽20份、青蒿30份、紫草30份、白茅根30份、地丁30份、知母20份、甘草15份。
实施例4
一种治疗艾滋病相关的肺部感染的中药组合物,其特征在于,所述中药组合物由如下重量份数的原料组成:生石膏4份、生地25份、地骨皮25份、葛根25份、天花粉25份、秦艽15份、青蒿25份、紫草20份、白茅根25份、地丁20份、知母15份、甘草10份。
实施例5
一种治疗艾滋病相关的肺部感染的中药组合物,其特征在于,所述中药组合物由如下重量份数的原料组成:生石膏20份、生地15份、地骨皮15份、葛根15份、天花粉15份、秦艽8份、青蒿15份、紫草10份、白茅根15份、地丁12份、知母8份、甘草3份。
实施例6
一种治疗艾滋病相关的肺部感染的中药制剂,所述中药制剂由实施例1至5所述的中药组合物按照常规方法制成汤剂。
实施例7
一种治疗艾滋病相关的肺部感染的中药制剂,所述中药制剂由实施例1至5所述的中药组合物和药学上可接受的载体或稀释剂组成;所述药学上可接受的载体或稀释剂是指药学领域常规的药物载体,选自填充剂、粘合剂、崩解剂、润滑剂、表面活性剂或矫味剂中的一种或几种。所述填充剂选自淀粉、蔗糖、乳糖、甘露醇、山梨醇、木糖醇、微晶纤维素或葡萄糖中的一种或几种。所述粘合剂选自纤维素衍生物、藻酸盐、明胶或聚乙烯吡咯烷酮中的一种
或几种。其制备方法如下:
取实施例1至5所述的中药组合物,将上述原料粉碎后,添加药学上可接受的载体或稀释剂,按照常规方法,整粒,干燥,制得中药颗粒剂。
实施例8
一种治疗艾滋病相关的肺部感染的中药制剂,所述中药制剂由实施例1至5所述的中药组合物和药学上可接受的载体或稀释剂组成;所述药学上可接受的载体或稀释剂是指药学领域常规的药物载体,选自填充剂、粘合剂、崩解剂、润滑剂、表面活性剂或矫味剂中的一种或几种。所述填充剂选自淀粉、蔗糖、乳糖、甘露醇、山梨醇、木糖醇、微晶纤维素或葡萄糖中的一种或几种。所述粘合剂选自纤维素衍生物、藻酸盐、明胶或聚乙烯吡咯烷酮中的一种或几种。其制备方法如下:
取实施例1至5所述的中药组合物,将上述原料粉碎后,添加药学上可接受的载体或稀释剂,按照常规方法,制粒,填充胶囊,制得中药胶囊剂。
实施例9
一种治疗艾滋病相关的肺部感染的中药制剂,所述中药制剂由实施例1至5所述的中药组合物和药学上可接受的载体或稀释剂组成;所述药学上可接受的载体或稀释剂是指药学领域常规的药物载体,选自填充剂、粘合剂、崩解剂、润滑剂、表面活性剂或矫味剂中的一种或几种。所述填充剂选自淀粉、蔗糖、乳糖、甘露醇、山梨醇、木糖醇、微晶纤维素或葡萄糖中的一种或几种。所述粘合剂选自纤维素衍生物、藻酸盐、明胶或聚乙烯吡咯烷酮中的一种或几种。其制备方法如下:
取实施例1至5所述的中药组合物,将上述原料粉碎后,添加药学上可接受的载体或稀释剂,按照常规塑制法或泛制法,制得中药丸剂。
实施例10
一种治疗艾滋病相关的肺部感染的中药制剂,所述中药制剂由实施例1至5所述的中药组合物和药学上可接受的载体或稀释剂组成;所述药学上可接受的载体或稀释剂是指药学领域常规的药物载体,选自填充剂、粘合剂、崩解剂、润滑剂、表面活性剂或矫味剂中的一种或几种。所述填充剂选自淀粉、蔗糖、乳糖、甘露醇、山梨醇、木糖醇、微晶纤维素或葡萄糖中的一种或几种。所述粘合剂选自纤维素衍生物、藻酸盐、明胶或聚乙烯吡咯烷酮中的一种或几种。其制备方法如下:
取实施例1至5所述的中药组合物,将上述原料粉碎后,添加药学上可接受的载体或稀释剂,按照常规方法,压制成片,包薄膜衣,制得中药片剂。
实施例11
一种治疗艾滋病相关的肺部感染的中药制剂,所述中药制剂由实施例1至5所述的中药组合物和药学上可接受的载体或稀释剂组成;所述药学上可接受的载体或稀释剂是指药学领域常规的药物载体,选自填充剂、粘合剂、崩解剂、润滑剂、表面活性剂或矫味剂中的一种或几种。所述填充剂选自淀粉、蔗糖、乳糖、甘露醇、山梨醇、木糖醇、微晶纤维素或葡萄糖中的一种或几种。所述粘合剂选自纤维素衍生物、藻酸盐、明胶或聚乙烯吡咯烷酮中的一种或几种。其制备方法如下:
取实施例1至5所述的中药组合物,将上述原料粉碎后,添加药学上可接受的载体或稀释剂如蔗糖等,按照常规方法,制得中药糖浆剂。
实验例
经过临床实验证实,本发明提供的中药组合物用于治疗艾滋病相关的肺部感染疗效确切。
1、一般资料
在医院长期接受抗逆转录病毒治疗的患者中挑选了70名存在艾滋病相关的肺部感染的患者,男性患者58名,女性患者12名;其中,20岁—29岁有18例,30岁—39岁有41例,40岁以上的11例。
2、治疗方法
治疗疗程:4周为一个疗程。
服药方法:将实施例1的中药组合物制成中药汤剂口服,每日两次,早晚各一次,饭前半小时服用,每次200~300毫升。服药期间,忌食油腻、猪肉以及绿豆等性寒食物。
3、诊断标准
同时满足以下两个标准:
3.1艾滋病诊断标准:参照《艾滋病和艾滋病病毒感染诊断标准》(WS293-2008)、《艾滋病诊疗指南(2011版)》,有流行病学史,结合抗HIV阳性,经Western Blot确证试验证实;或仅实验室检查抗HIV阳性即可诊断。
3.2肺部感染标准:
参照《成人呼吸系统感染性疾病病原学诊断专家意见》,诊断主要依据发热、呼吸困难等症状体征、病原学和血清学等实验室检查以及影像学检查。组织活检标本是诊断金标准。
4、疗效评定标准:证候疗效判定标准参照《中药新药临床研究指导原则(试行)》(中国医药科技出版社,2002)制定。
显效:症状、体征明显改善,证候积分减少≥70%;
有效:症状、体征均有好转,证候积分减少≥30%;
无效:症状、体征均无明显改善,甚或加重,证候积分减少不足30%。计算公式(尼莫地平法)为:疗效指数=[(治疗前积分—治疗后积分)÷治疗前积分]×100%。
5、治疗结果
接受治疗的患者中,显效28例,有效29例,无效13例。从治疗结果来看,说明本发明提供的中药组合物用于改善艾滋病相关的肺部感染的有效率达81.4%,疗效确切。
典型案例
病例1:张某某,男,45岁,同性恋者。2018年3月无明显诱因出现胸闷、咳嗽咳痰、气短,为阵发性咳嗽,痰白而粘,不易咳出,伴有乏力、头晕,于当地医院就诊确诊为感染性肺炎。随后来北京地坛医院就诊,诊断HIV阳性。HIV抗体检测为阳性,HIV病载3.5×105copies/ml,全血CD4+T淋巴细胞计数95μL-1,给予抗HIV治疗方案3TC/TDF/EFV。给予实施例1的中药组合物制成的中药汤剂联合磺胺等治疗肺部感染,1周后症状明显好转,2周胸闷咳嗽症状消失,乏力症状明显改善,随后继续服用中药汤剂治疗,期间无复发且无不良反应。继续服用原方案抗HIV治疗。
病例2:崔某某,男,38岁,河北保定人。2019年11月无明显诱因出现喘憋、胸闷等症状。随后于北京地坛医院就诊,CT提示双肺磨玻璃影改变。此外,检测HIV抗体阳性,HIV病载3.0×106copies/ml,全血CD4+T淋巴细胞计数76μL-1,诊断为艾滋病、肺孢子菌肺炎,给予实施例1的中药组合物制成的中药汤剂联合磺胺等抗感染治疗1周,肺部症状好转。给予抗HIV治疗方案3TC/TDF/EFV。继续服用至4周,患者肺部症状消失,期间无复发及不良反应。继续服用原方案抗HIV治疗。
病例3:王某某,男,39岁,北京海淀人,同性恋者。2019年5月无明显诱因出现发热、乏力、干咳、胸闷,呼吸困难。随后来北京地坛医院就诊,胸部CT显示双肺弥漫性磨玻璃影,其间可见支气管血管束。HIV抗体检测为阳性,HIV病载5.6×105copies/ml,全血CD4+T淋巴细胞计数55μL-1,诊断为肺孢子菌肺炎、艾滋病。给予实施例2的中药组合物制成的中药汤剂联合磺胺等抗感染治疗2周,肺部症状明显好转。同时启动抗HIV治疗,治疗方案3TC/TDF/EFV。4周后,肺部症状消失,无不良反应,期间病情稳定未复发。复查CD4+T细胞计数上升至180μL-1。继续服用原方案抗HIV治疗。
虽然,上文中已经用一般性说明及具体实施例对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
Claims (8)
1.一种治疗艾滋病相关的肺部感染的中药组合物,其特征在于,所述中药组合物由如下重量份数的原料组成:生石膏15-45份、生地10-30份、地骨皮10-30份、葛根10-30份、天花粉10-30份、秦艽5-20份、青蒿10-30份、紫草5-30份、白茅根10-30份、地丁5-30份、知母5-20份、甘草2-15份。
2.如权利要求1所述的一种治疗艾滋病相关的肺部感染的中药组合物,其特征在于,所述中药组合物由如下重量份数的原料组成:生石膏20-40份、生地15-25份、地骨皮15-25份、葛根15-25份、天花粉15-25份、秦艽6-15份、青蒿15-25份、紫草10-20份、白茅根15-25份、地丁10-20份、知母6-15份、甘草2-10份。
3.如权利要求2所述的一种治疗艾滋病相关的肺部感染的中药组合物,其特征在于,所述中药组合物由如下重量份数的原料组成:生石膏30份、生地20份、地骨皮20份、葛根20份、天花粉20份、秦艽10份、青蒿20份、紫草15份、白茅根20份、地丁15份、知母10份、甘草5份。
4.一种治疗艾滋病相关的肺部感染的中药制剂,其特征在于,所述中药制剂由权利要求1-3任一项所述的中药组合物和药学上可接受的载体或稀释剂组成。
5.如权利要求4所述的中药制剂,其特征在于,所述中药制剂为颗粒剂、片剂、胶囊、丸剂、汤剂、糖浆剂。
6.如权利要求4所述的中药制剂,其特征在于,所述药学上可接受的载体或稀释剂是指药学领域常规的药物载体,选自填充剂、粘合剂、崩解剂、润滑剂、表面活性剂或矫味剂中的一种或几种。
7.如权利要求6所述的中药制剂,其特征在于,所述填充剂选自淀粉、蔗糖、乳糖、甘露醇、山梨醇、木糖醇、微晶纤维素或葡萄糖中的一种或几种。
8.如权利要求6所述的中药制剂,其特征在于,所述粘合剂选自纤维素衍生物、藻酸盐、明胶或聚乙烯吡咯烷酮中的一种或几种。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311321048.8A CN117482167A (zh) | 2023-10-12 | 2023-10-12 | 一种治疗艾滋病相关的肺部感染的中药组合物及其中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311321048.8A CN117482167A (zh) | 2023-10-12 | 2023-10-12 | 一种治疗艾滋病相关的肺部感染的中药组合物及其中药制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117482167A true CN117482167A (zh) | 2024-02-02 |
Family
ID=89683805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311321048.8A Pending CN117482167A (zh) | 2023-10-12 | 2023-10-12 | 一种治疗艾滋病相关的肺部感染的中药组合物及其中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117482167A (zh) |
-
2023
- 2023-10-12 CN CN202311321048.8A patent/CN117482167A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112353855A (zh) | 中药组合物在制备辅助治疗新型冠状病毒肺炎的药物中的应用 | |
CN111388582B (zh) | 一种用于新型冠状病毒肺炎的中药组合物及其制剂的应用 | |
CN100358549C (zh) | 一种治疗腹泻病的中药组合物 | |
CN111671867B (zh) | 用于治疗轻症的新型冠状病毒肺炎咳嗽的中药组合物 | |
CN111671880A (zh) | 用于治疗冠状病毒肺炎发热的中药制剂 | |
WO2021179505A1 (zh) | 一种翘芪复方制剂及其制备方法和用途 | |
CN111569010B (zh) | 一种中药组合物及其在制备治疗新冠肺炎的药物中的应用 | |
CN116139237B (zh) | 一种防治新型冠状病毒等所致呼吸道感染的中药组合物及其应用 | |
CN106138668A (zh) | 一种治疗慢性阻塞性肺疾病的中药组合物及其制备方法 | |
CN117482167A (zh) | 一种治疗艾滋病相关的肺部感染的中药组合物及其中药制剂 | |
CN117482170A (zh) | 一种治疗艾滋病相关性痒疹的中药组合物及其中药制剂 | |
CN104189649A (zh) | 一种治疗复发性生殖器疱疹的中药组合物 | |
CN112263656B (zh) | 一种治疗艾滋病相关睡眠障碍的中药组合物及其中药制剂 | |
CN103301244A (zh) | 一种治疗小儿肺炎的中药制剂及其制备方法 | |
CN102727605B (zh) | 一种治疗病毒性心肌炎的口服液 | |
CN101637533B (zh) | 一种中药组合物在制备治疗病毒性心肌炎药物中的应用 | |
CN116407597B (zh) | 一种抗冠状病毒的宣白生脉汤及其制备方法 | |
CN101385810B (zh) | 一种含有龟板的治疗皮肌炎的中药组合物及其制剂 | |
CN101385836B (zh) | 一种含有云苓的治疗皮肌炎的中药组合物及其制剂 | |
CN106581468A (zh) | 一种能够治疗胃溃疡的中药制备方法 | |
CN105770520A (zh) | 一种用于治疗冠心病的药物制剂及其用途 | |
CN117462646A (zh) | 一种治疗艾滋病相关的慢性腹泻的中药组合物及其中药制剂 | |
CN117462641A (zh) | 一种治疗艾滋病相关的带状疱疹的中药组合物及其中药制剂 | |
CN106138687A (zh) | 一种防治肾虚型哮喘的中药组合物 | |
CN118697832A (zh) | 治疗肾性血尿的参草根方及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |